A clinical trial of an Alzheimer’s disease treatment developed found that the nutrient cocktail can improve memory in patients with early Alzheimer’s. The mixture appears to increase the number of dendritic spines and therefore some synapses.
Roke Manor Research Ltd has developed the world's first threat monitoring system for autonomous vehicles that emulates a mammal's conditioned fear-response mechanism.
An experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy has been created.
Penn Medicine research presented today at the 2012 Alzheimer's Association International Conference shows that an anti-tau treatment called epithilone D (EpoD) was effective in preventing and intervening the progress of Alzheimer's disease in animal models, improving neuron function and cognition, as well as decreasing tau pathology.
Researchers announced that the UK’s first operation to tackle heart failure with a novel nerve-stimulating device will be performed today. The implantable device operates by stimulating the vagus nerve on the right side of the neck.
Rensselaer becomes the first university of receive a version of IBM's Watson system. Rensselaer hopes to find new uses for Watson and develop its cognitive capabilities, as well as using the system for Big Data research.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
Researchers have carried out the largest general neural network simulation to date using the computational power of the K computer.
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer's disease. They also identify possible causes of early onset hereditary forms of AD.